Physician profile
Joseph Mcphee
NPI 1336217165
$8,583.47
in general payments reported to CMS, 2019-2025
7 companies · $5,553 in 2025
The $5,553 reported for 2025 was more than what 80% of Obesity Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $203).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $225 · 2021: $145 · 2022: $250 · 2023: $1,775 · 2024: $449 · 2025: $5,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Consulting Fee: $1,680 · Travel and Lodging: $1,439 · Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Consulting Fee | $1,680.00 |
| Travel and Lodging | $1,438.72 |
| Food and Beverage | $657.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,536.92 | 2025 | |
| Medical Device Business Services, INC. | $1,680.00 | 2023 | Echelon; Endopath |
| W. L. Gore & Associates, INC. | $946.16 | 2019-2024 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Intra-Sana Laboratories | $147.73 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Ethicon US, LLC | $145.68 | 2020-2025 | Monocryl, Echelon Flex, Stratafix |
| Novo Nordisk INC | $106.84 | 2019-2024 | Wegovy, Saxenda |
| Lilly USA, LLC | $20.14 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mcphee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.